Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Attention Deficit Hyperactivity Disorder: A Neurological Cramp


Affiliations
1 Department of Pharmacology, Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
2 Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
     

   Subscribe/Renew Journal


Attention deficit hyperactivity disorder (ADHD) is also referred as attention deficit disorder (ADD) is a neurological disorder usually found in children of elementary school age. This condition begins in childhood. There are mainly three types of ADHD include predominantly inattentive presentation, predominantly hyperactive-impulsive presentation and combined presentation. Both genetic and environmental factors contribute to development of ADHD .The neurotransmitters dopamine and norepinephrine are also involved in occurrence of ADHD. There's no specific test for diagnosis of ADHD. Standard treatments for ADHD in children include stimulant medications, education, training and counseling.

Keywords

ADHD, ADD, Dopamine, Norepinephrine, Stimulant Medications.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Gilliam M, Stockman M, Malek M, Sharp W, Greenstein D, et al. Developmental trajectories of the corpus callosum in attention deficit/hyperactivity disorder. Biol Psychiatry. 2011 May 1;69(9):839-46. Epub 2011 Jan 17. PMID: 21247556.

  • Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 2010 Mar;33(1):159-80. Review. PubMed PMID: 20159345; PubMed Central PMCID: PMC 2847260.

  • Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009 Jul;126(1):51- 90. Epub 2009 Jun 9. Review. PubMed PMID: 19506906.

  • Shaw P, Gornick M, Lerch J, Addington A, Seal J, et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007 Aug;64(8):921-31. PMID: 17679637.

  • Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 2011 Dec 4;44(1):78- 84. doi: 10.1038/ng.1013. PMID: 22138692.

  • Williams NM, Franke B, Mick E, Anney RJ, Freitag CM, et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry. 2012 Feb;169(2):195-204. PMID: 22420048.

  • National Institutes of Health (NIH) Consensus Statement on the Diagnosis and Treatment of ADHD. NIH Consensus Statement. 1998;16:1-37.

  • Le Fever GB, Dawson KV, Morrow AL. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health. 1999;89:1359-1364.

  • Zito JM, Safer DJ, dos Reis S, et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283:1025-1030.

  • Hoagwood K, Kelleher KJ, Feil M, et al. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry. 2000;39:198-206.

  • MTA Group. Moderators and mediators of treatment response for children with ADHD: the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1088-1096.

  • Amen DG. Change Your Brain, Change Your Life. New York, NY: Three Rivers Press; 1998.

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

  • Levy, F., Hay, D.A., McStephen, M., Wood, C., & Waldman, I. (1997). Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 737-744.

  • Millichap JG, Yee MM. The diet factor in attention deficit/hyperactivity disorder. Pediatrics. 2012 Feb;129(2):330- 7. Epub 2012 Jan 9. Review. PubMed PMID: 22232312.

  • Nigg JT, Lewis K, Edinger T, Falk M. Meta-analysis of attention deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):86-97.e8. PMID: 22176942.

  • Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148:56477.


Abstract Views: 333

PDF Views: 1




  • Attention Deficit Hyperactivity Disorder: A Neurological Cramp

Abstract Views: 333  |  PDF Views: 1

Authors

D. Rajesh Kumar
Department of Pharmacology, Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
P. Prathap Reddy
Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
V. Sai Krishna
Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
B. Manikanta
Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
D. Naga Jyothi
Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India
K. Samrajyam
Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda, Narsaraopet, Guntur (DT) A.P., India

Abstract


Attention deficit hyperactivity disorder (ADHD) is also referred as attention deficit disorder (ADD) is a neurological disorder usually found in children of elementary school age. This condition begins in childhood. There are mainly three types of ADHD include predominantly inattentive presentation, predominantly hyperactive-impulsive presentation and combined presentation. Both genetic and environmental factors contribute to development of ADHD .The neurotransmitters dopamine and norepinephrine are also involved in occurrence of ADHD. There's no specific test for diagnosis of ADHD. Standard treatments for ADHD in children include stimulant medications, education, training and counseling.

Keywords


ADHD, ADD, Dopamine, Norepinephrine, Stimulant Medications.

References